Feeds
20859 items (20859 unread) in 74 feeds
Acinar Cell Carcinoma
(201 unread)
Acinic Cell Carcinoma
(104 unread)
Adenoid Cystic Carcinoma
(367 unread)
Adrenal Gland Cancer
(1718 unread)
Ampulla Of Vater
(213 unread)
Anal Cancer
(1799 unread)
Angiosarcoma
(359 unread)
Appendix Cancer
(450 unread)
Bile Duct Cancer
(2698 unread)
Brain and CNS
(2597 unread)
Carcinoid
(671 unread)
Endocrine/Neuroendocrine
(2404 unread)
Gall Bladder Cancer
(1146 unread)
Hemangioendothelioma
(506 unread)
Hepatoblastoma
(366 unread)
Pancreas
(416 unread)
Phyllodes
(215 unread)
PMP and Mucinous Tumors
(242 unread)
Rhabdomyosarcoma
(772 unread)
Sarcoma
(3615 unread)
Google - Angiosarcoma (100 unread)
1
2
-
3 “Strong Buy” Stocks Under $10 With Over 100% Upside Potential - Nasdaq
Posted: June 18th, 2021, 12:08pm GMT
-
Why two scientific powerhouses are teaming up to tackle rare cancers long overlooked in research - STAT
Posted: June 15th, 2021, 6:35am GMT
-
Sarcoma Drugs Market 2021 Business Development, Size, Share and COVID-19 Impact Analysis 2028 – The Manomet Current - The Manomet Current
Posted: June 14th, 2021, 3:48pm GMT
-
Angiosarcomas Treatment Market is Predicted to See Lucrative Gains Over 2021-2027 Covid-19 Analysis – The Courier - The Courier
Posted: June 11th, 2021, 9:11am GMT
-
Top Key-Players To Re-Define Growth For The Soft Tissue Sarcoma Treatment Market – The Courier - The Courier
Posted: June 7th, 2021, 4:24pm GMT
-
Gene-edited T-cell therapy shows 'promising efficacy' for rare sarcomas - Healio
Posted: June 4th, 2021, 7:39pm GMT
-
Molecular Diagnostics Market to Show Robust Growth During the Forecast Period | TechSci Research - MENAFN.COM
Posted: June 3rd, 2021, 5:22am GMT
-
Molecular Diagnostics Market to Show Robust Growth During the Forecast Period | TechSci Research - MENAFN.COM
Posted: June 3rd, 2021, 5:22am GMT
-
Molecular Diagnostics Market to Show Robust Growth During the Forecast Period | TechSci Research - openPR
Posted: June 3rd, 2021, 3:16am GMT
-
Orphan Drugs Market Forthcoming Developments in Pandemic Outbreak 2020 to 2027 By AbbVie Inc., Bristol-Myers S - openPR
Posted: June 1st, 2021, 4:47pm GMT
-
Angiosarcoma Treatment Market 2021 Development Plans of Top Companies – Genetech, Inc., Sanofi SA, Bayer AG, Johnson & Johnson, and Others. – KSU | The Sentinel Newspaper - KSU | The Sentinel Newspaper
Posted: May 31st, 2021, 11:35am GMT
-
Liver Cancer Latest Facts: Causes, Risk Factors, Symptoms, Prognosis, and Treatment - Gilmore Health News
Posted: May 31st, 2021, 9:23am GMT
-
Angiosarcomas Treatment Market Best Productivity Supply Chain Relationship, Development by 2027 – Clark County Blog - Clark County Blog
Posted: May 31st, 2021, 8:57am GMT
-
Liver Angiosarcoma Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types a Market Research Methods that Will Give You Proven Results | Forecast 2021-2027 | – KSU | The Sentinel Newspaper - KSU | The Sentinel New
Posted: May 28th, 2021, 8:59am GMT
-
Iatrogenic immunosuppression can lead to prolonged viral shedding and absent immune response to COVID‐19 - Wiley
Posted: May 27th, 2021, 5:00am GMT
-
Iatrogenic immunosuppression can lead to prolonged viral shedding and absent immune response to COVID-19 - DocWire News
Posted: May 27th, 2021, 4:00am GMT
-
Angiosarcomas Treatment Market With Top 20 Countries Data, Share, Growth By Key Players, Geographical Region, Application, Driver, Trends & Forecast From 2020-2027 – KSU | The Sentinel Newspaper - KSU | The Sentinel Newspaper
Posted: May 25th, 2021, 8:41am GMT
-
'There's so much freedom out here': life in the outback offers thrills, but population dwindles - The Guardian
Posted: May 23rd, 2021, 12:03am GMT
-
Global Sarcoma Drugs Market To Witness Widespread Expansion During 2020-2027 – The Manomet Current - The Manomet Current
Posted: May 22nd, 2021, 5:47am GMT
-
Tocilizumab holds firm as steroid-sparing agent in giant cell arteritis - Healio
Posted: May 21st, 2021, 3:57pm GMT
-
Global Sarcoma Drugs Market Growth Factors, Business Developments, Segmentation and Technologies 2021-2026 – The Manomet Current - The Manomet Current
Posted: May 20th, 2021, 6:01pm GMT
-
Form 10-K Replimune Group, Inc. For: Mar 31 - StreetInsider.com
Posted: May 20th, 2021, 10:07am GMT
Form 10-K Replimune Group, Inc. For: Mar 31 StreetInsider.com -
Angiosarcoma Treatment Market Projected to Show Strong Growth | Pfizer Inc., Amgen Inc., Genetech, Inc., Sanofi SA – The Manomet Current - The Manomet Current
Posted: May 19th, 2021, 10:28am GMT
-
Angiosarcomas Treatment Market 2027: Research Methodology Focuses on Exploring Major Factors Influencing the Industry Development – Brockville Observer - Brockville Observer
Posted: May 15th, 2021, 11:01am GMT
-
Breast cancer types: Definitions, symptoms, treatments, and more - Medical News Today
Posted: May 14th, 2021, 7:03am GMT
Breast cancer types: Definitions, symptoms, treatments, and more Medical News Today -
Breast tumor consisting of 3 different types of malignancies | OTT - Dove Medical Press
Posted: May 13th, 2021, 8:50pm GMT
Breast tumor consisting of 3 different types of malignancies | OTT Dove Medical Press -
£15,000 raised for Lowestoft father with rare form of cancer - Lowestoft Journal
Posted: May 12th, 2021, 7:19am GMT
£15,000 raised for Lowestoft father with rare form of cancer Lowestoft Journal -
£15,000 raised for Lowestoft father with rare form of cancer - East Anglian Daily Times
Posted: May 12th, 2021, 7:19am GMT
£15,000 raised for Lowestoft father with rare form of cancer East Anglian Daily Times -
BC adjuvant radiotherapy in BRCA1/2, TP53,ATM genes mutation | BCTT - Dove Medical Press
Posted: May 12th, 2021, 10:18pm GMT
BC adjuvant radiotherapy in BRCA1/2, TP53,ATM genes mutation | BCTT Dove Medical Press -
Athenex Plant Nearly Complete | News, Sports, Jobs - Jamestown Post Journal
Posted: May 11th, 2021, 5:00am GMT
Athenex Plant Nearly Complete | News, Sports, Jobs Jamestown Post Journal -
Athenex plant 'nearly complete' | News, Sports, Jobs - Evening Observer
Posted: May 11th, 2021, 4:35am GMT
Athenex plant 'nearly complete' | News, Sports, Jobs Evening Observer -
Roundtable Discussion: Finding Targets for Adjuvant NSCLC Treatment - Targeted Oncology
Posted: May 10th, 2021, 1:07pm GMT
Roundtable Discussion: Finding Targets for Adjuvant NSCLC Treatment Targeted Oncology -
Tributes pour in for popular Exeter Greek chef who died on his 41st birthday - Devon Live
Posted: May 8th, 2021, 11:20am GMT
-
Athenex, Inc. (ATNX) CEO Johnson Lau on Q1 2021 Results - Earnings Call Transcript - Seeking Alpha
Posted: May 8th, 2021, 5:00am GMT
-
Athenex, Inc. (ATNX) Q1 2021 Earnings Call Transcript - Motley Fool
Posted: May 7th, 2021, 7:00pm GMT
-
TRACON Pharmaceuticals (TCON) CEO Charles Theuer on Q1 2021 Results - Earnings Call Transcript - Seeking Alpha
Posted: May 6th, 2021, 2:10pm GMT
-
Angiosarcomas Treatment Market: Increasing Investments in Healthcare Sector of the Country to Boost Growth – KSU | The Sentinel Newspaper - KSU | The Sentinel Newspaper
Posted: May 3rd, 2021, 9:33am GMT
-
Replimune: Oncolytic Immunotherapy Pioneer Gaining Momentum In The Clinic - Seeking Alpha
Posted: April 30th, 2021, 3:29pm GMT
-
John Byl legacy part of Sioux Center history - nwestiowa.com
Posted: April 30th, 2021, 12:00pm GMT
John Byl legacy part of Sioux Center history nwestiowa.com -
Angiosarcomas Treatment Market to Witness Unprecedented Growth By 2027 – The Courier - The Courier
Posted: April 23rd, 2021, 10:00am GMT
-
▷ DNA Sequencing Test Proves Effective in Detecting Mesothelioma - MesoWatch
Posted: April 21st, 2021, 4:11pm GMT
-
EP. 8: TRK Fusion Inhibitors in Tumor-Agnostic Clinical Trials - OncLive
Posted: April 21st, 2021, 5:00am GMT
-
Canine cancer research startup impacts treatment in humans Patient centricity - OutSourcing-Pharma.com
Posted: April 19th, 2021, 11:36am GMT
Canine cancer research startup impacts treatment in humans Patient centricity OutSourcing-Pharma.com -
Andrew's 4x4x48 endurance inspires his mum Patricia - The Argus
Posted: April 16th, 2021, 9:00pm GMT
-
Clinical characteristics and surgical treatments of primary hepatic angiosarcoma - MD Linx
Posted: April 16th, 2021, 12:45pm GMT
-
[Full text] CT and MRI findings of head and neck Masson's tumor | RMI - Dove Medical Press
Posted: April 14th, 2021, 8:09pm GMT
CT and MRI findings of head and neck Masson's tumor | RMI Dove Medical Press -
Soft Tissue Sarcomas Treatment Market Poised for Growth | Key Players – Sanofi, Cardinal Health, Merck KGaA. – KSU | The Sentinel Newspaper - KSU | The Sentinel Newspaper
Posted: April 14th, 2021, 9:47am GMT
-
Who Is Natalie Viscuso? Meet Henry Cavill's New Girlfriend - ELLE Australia
Posted: April 12th, 2021, 9:15pm GMT
Who Is Natalie Viscuso? Meet Henry Cavill's New Girlfriend ELLE Australia -
Angiosarcomas Treatment Market Size Will Escalate Rapidly in the Near Future - The Courier
Posted: April 12th, 2021, 8:28am GMT
-
Angiosarcomas Treatment Market Size Will Escalate Rapidly in the Near Future – The Courier - The Courier
Posted: April 12th, 2021, 5:00am GMT
-
5 things to know about Henry Cavill's new girlfriend Natalie Viscuso - 9TheFIX
Posted: April 12th, 2021, 10:50pm GMT
-
Desiccated "Ghost Forests," Killed by Rising Ocean, Can Be Seen From Space - Futurism
Posted: April 8th, 2021, 5:00am GMT
-
Dr. Wagner on the Rationale for Immunotherapy in Angiosarcoma - OncLive
Posted: April 5th, 2021, 6:23pm GMT
-
A Pilot Study of Lenvatinib and Pembrolizumab Immunotherapy in People with Advanced Soft Tissue Sarcoma - On Cancer - Memorial Sloan Kettering
Posted: April 5th, 2021, 3:38pm GMT
A Pilot Study of Lenvatinib and Pembrolizumab Immunotherapy in People with Advanced Soft Tissue Sarcoma On Cancer - Memorial Sloan Kettering -
Michael Greenwood Obituary (2021) - Phoenix, AZ - The Arizona Republic - Legacy.com
Posted: April 1st, 2021, 5:00am GMT
-
FDA Grants Fast Track Designation to Investigational Anthracycline Annamycin for STS Lung Metastases - Cancer Network
Posted: March 30th, 2021, 5:00am GMT
-
A Phase II Study Assessing the Addition of Nivolumab to Chemotherapy to Treat Angiosarcoma - On Cancer - Memorial Sloan Kettering
Posted: March 23rd, 2021, 2:10pm GMT
A Phase II Study Assessing the Addition of Nivolumab to Chemotherapy to Treat Angiosarcoma On Cancer - Memorial Sloan Kettering -
Angiosarcomas Treatment Market 2020 – Precise Outlook, Status & Forecast Till 2027 – Jumbo News - Jumbo News
Posted: March 22nd, 2021, 9:49am GMT
-
Heart Tumor Market to Hit CAGR of +7% 2028 | Tomtec Imaging Systems GmBh, Koninklijke Philips N.V., Siemens Healthineers, Circle Cardiovascular Imaging Inc., Toshiba Corporation, Shimadzu Corporation, CardioComm Solutions Inc., Integer Holdings Corporati
Posted: March 22nd, 2021, 8:10am GMT
-
[Full text] Tyrosine Kinase Inhibitors in Soft Tissue Sarcoma | CMAR - Dove Medical Press
Posted: March 17th, 2021, 6:48pm GMT
Tyrosine Kinase Inhibitors in Soft Tissue Sarcoma | CMAR Dove Medical Press -
Verna Boyd Obituary (2021) - Hanover, VA - Richmond Times-Dispatch - Legacy.com
Posted: March 15th, 2021, 5:00am GMT
-
Managing Menopausal Symptoms in Young Women With Breast Cancer: When Medicine Is Not All. The Take Care Project. - Physician's Weekly
Posted: March 11th, 2021, 6:00am GMT
-
Hepatic vascular malignancies in children are associated with increased rates of surgical resection and improved overall survival compared with adults - MD Linx
Posted: March 10th, 2021, 7:20pm GMT
-
Angiosarcomas Treatment Market SWOT Analysis, Segmentation, Applications & Emerging Audience Till 2027 – Breakout Live - Breakout Live
Posted: March 9th, 2021, 11:48am GMT
-
'Unintended consequences': The rubber industry's toxic legacy in Akron – Center for Public Integrity - Center for Public Integrity
Posted: March 5th, 2021, 3:37pm GMT
'Unintended consequences': The rubber industry's toxic legacy in Akron – Center for Public Integrity Center for Public Integrity -
Stage 4 Liver Cancer: Overview and More - Verywell Health
Posted: March 5th, 2021, 6:00am GMT
Stage 4 Liver Cancer: Overview and More Cancer in the liver Verywell Health -
Sarcoma Drugs Market Present Scenario, Key Vendors, Industry Share, and Growth Forecast up to 2027 - The Courier
Posted: March 4th, 2021, 5:56pm GMT
-
Nonprofit Count Me In to Return Genomic Results to Patients With Rare Cancers - GenomeWeb
Posted: March 3rd, 2021, 6:00pm GMT
-
Nonprofit Count Me In to Return Genomic Results to Patients With Rare Cancers - Precision Oncology News
Posted: March 3rd, 2021, 6:00pm GMT
Nonprofit Count Me In to Return Genomic Results to Patients With Rare Cancers Precision Oncology News -
Dr. Wagner on the Safety Profile of Nivolumab/Ipilimumab in Angiosarcoma - OncLive
Posted: March 2nd, 2021, 8:41pm GMT
-
Angiosarcomas Treatment Market 2019 Trends, Size Analysis, Share, Leading Companies, Future Insight - PharmiWeb.com
Posted: March 2nd, 2021, 8:10am GMT
-
Global Soft Tissue Sarcomas Treatment Market Is Growing With A CAGR Of 6.49% 2021-2028 | Sanofi, Car - PharmiWeb.com
Posted: March 2nd, 2021, 6:29am GMT
-
Athenex, Inc. (ATNX) Q4 2020 Earnings Call Transcript - Motley Fool
Posted: March 1st, 2021, 9:30pm GMT
-
Phio, AgonOx Collaborate To Develop T Cell-based Cancer Immunotherapies - Quick Facts - Nasdaq
Posted: March 1st, 2021, 11:11am GMT
-
Edited Transcript of ATNX.OQ earnings conference call or presentation 1-Mar-21 1:00pm GMT - Yahoo Finance
Posted: March 1st, 2021, 11:00am GMT
-
Athenex Provides Fourth Quarter and Full Year 2020 Corporate and Financial Update - StreetInsider.com
Posted: March 1st, 2021, 10:08am GMT
-
Athenex Provides Fourth Quarter and Full Year 2020 Corporate and Financial Update - StreetInsider.com
Posted: March 1st, 2021, 10:05am GMT
-
Athenex Provides Fourth Quarter and Full Year 2020 Corporate and Financial Update - GlobeNewswire
Posted: March 1st, 2021, 6:00am GMT
-
Athenex Provides Fourth Quarter and Full Year 2020 Corporate and Financial Update - GlobeNewswire
Posted: March 1st, 2021, 6:00am GMT
-
Taking A Gander At Tracon Pharmaceuticals - Seeking Alpha
Posted: February 28th, 2021, 4:58am GMT
Taking A Gander At Tracon Pharmaceuticals Seeking Alpha -
Taking A Gander At Tracon Pharmaceuticals - Seeking Alpha
Posted: February 28th, 2021, 4:58am GMT
Taking A Gander At Tracon Pharmaceuticals Seeking Alpha -
TRACON Pharmaceuticals, Inc. (TCON) CEO Charles Theuer on Q4 2020 Results - Earnings Call Transcript - Seeking Alpha
Posted: February 27th, 2021, 8:36pm GMT
-
Healthcare Industry: Global Soft Tissue Sarcomas Treatment Market s growing with a CAGR of 6.49% 2021-2028 – The Bisouv Network - The Bisouv Network
Posted: February 25th, 2021, 8:45am GMT
-
Impact of Covid-19 on Global Soft Tissue Sarcomas Treatment Market s growing with a CAGR of 6.49% 2021-2028 – The Courier - The Courier
Posted: February 25th, 2021, 8:31am GMT
-
Global Soft Tissue Sarcomas Treatment Market is growing with a CAGR of 6.49% 2021-2028 | Sanofi, Cardinal Health, Merck KGaA, Pfizer, Bristol-Myers Squibb Company, Johnson & Johnson Services – KSU | The Sentinel Newspaper - KSU | The Sentinel Newspaper
Posted: February 25th, 2021, 8:18am GMT
-
Former patient drives cancer community - Sandton Chronicle
Posted: February 25th, 2021, 6:44am GMT
Former patient drives cancer community Sandton Chronicle -
Randy Rosen Rink officially named after hockey coach with terminal cancer - FortSaskOnline.com
Posted: February 21st, 2021, 3:12pm GMT
Randy Rosen Rink officially named after hockey coach with terminal cancer FortSaskOnline.com -
Next-Generation Sequencing Unearths Actionable Mutations in Sarcoma - www.oncnursingnews.com/
Posted: February 21st, 2021, 3:06pm GMT
Next-Generation Sequencing Unearths Actionable Mutations in Sarcoma www.oncnursingnews.com/ -
Canine Hemangiosarcoma – Cancer in Dogs - The Bark
Posted: February 19th, 2021, 6:54am GMT
-
Right atrial cardiac angiosarcoma treated with concurrent proton beam therapy and paclitaxel: A novel approach to a rare disease - DocWire News
Posted: February 19th, 2021, 4:00am GMT
-
Next-Generation Sequencing Reveals Potentially Actionable Mutations in Sarcoma - OncLive
Posted: February 18th, 2021, 2:02pm GMT
-
[Full text] Clinical Characteristics and Prognostic Factors in Pediatric Vascular | PHMT - Dove Medical Press
Posted: February 15th, 2021, 7:01pm GMT
Clinical Characteristics and Prognostic Factors in Pediatric Vascular | PHMT Dove Medical Press -
Ken Pribil Jr. Foundation Supports Angiosarcoma Research at Memorial Sloan Kettering Cancer Center for a Third Year - WFMZ Allentown
Posted: February 15th, 2021, 12:00pm GMT
-
Ken Pribil Jr. Foundation Supports Angiosarcoma Research at Memorial Sloan Kettering Cancer Center for a Third Year - PR Web
Posted: February 15th, 2021, 6:00am GMT
-
First Patient-Led Cancer Registry Launched With Support From Altron Karabina - Africa.com
Posted: February 10th, 2021, 5:23am GMT
-
Global SAR Market Research Report 2025 – NeighborWebSJ - NeighborWebSJ
Posted: February 10th, 2021, 11:15pm GMT
Global SAR Market Research Report 2025 – NeighborWebSJ NeighborWebSJ -
Sorrento Announces Subsidiary Company - ADNAB, Inc. - to Develop and Commercialize ADNAB™ Platform Products for Hematological Malignancies and Solid Tumors Based on an Exclusive Technology License From the Mayo Clinic - BioSpace
Posted: February 8th, 2021, 6:00am GMT
-
Massage And Cancer - The Weekly Post
Posted: February 8th, 2021, 6:00am GMT
Massage And Cancer The Weekly Post -
Study Finds Niraparib Plus Temozolomide or Irinotecan Tolerable in Pretreated Ewing Sarcoma - Cancer Network
Posted: February 6th, 2021, 6:00am GMT
-
First patient-led cancer registry launches with support from Altron Karabina on World Cancer Day - ITWeb
Posted: February 5th, 2021, 6:00am GMT
1
2